[1]侯建峰a,杨亚明,王 莉,等.谷氨酸脱氢酶在肝外胆管癌患者肿瘤组织中的表达及其临床意义[J].现代检验医学杂志,2018,33(06):13-16+20.[doi:10.3969/j.issn.1671-7414.2018.06.004]
　HOU Jian-fenga,YANG Ya-ming,WANG Li,et al.Expression and Clinical Significance of Glutamate Dehydrogenase in Tumor Tissues of Patients with Extrahepatic Cholangiocarcinoma[J].Journal of Modern Laboratory Medicine,2018,33(06):13-16+20.[doi:10.3969/j.issn.1671-7414.2018.06.004]
点击复制

谷氨酸脱氢酶在肝外胆管癌患者肿瘤组织中的表达及其临床意义()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年06期
页码:
13-16+20
栏目:
论著
出版日期:
2018-12-24

文章信息/Info

Title:
Expression and Clinical Significance of Glutamate Dehydrogenase in Tumor Tissues of Patients with Extrahepatic Cholangiocarcinoma
文章编号:
1671-7414(2018)06-013-05
作者:
侯建峰1a; 杨亚明2; 王 莉2; 王 莉1b
1.榆林市第一医院 a.肝胆外科; b.体检中心B超室,陕西榆林 719000; 2.宝鸡市第二中医医院内科,陕西宝鸡 721300
Author(s):
HOU Jian-feng1a; YANG Ya-ming2; WANG Li2; WANG Li1b
1a.Department of Hepatobiliary Surgery; 1b.B Ultrasonic Room of Health Inspection Center,the First Hospital of Yulin City,Shaanxi Yulin 719000,China; 2.Department of Internal Medicine,the Second Hospital of Traditional Chinese Medicine of Baoji City,ShaanxiBaoji 721300,China
关键词:
谷氨酸脱氢酶;  肝外胆管癌;  免疫组织化学;  预后
分类号:
R735.8; R730.43
DOI:
10.3969/j.issn.1671-7414.2018.06.004
文献标志码:
A
摘要:
目的 探讨肝外胆管癌(ECC)患者肿瘤组织中谷氨酸脱氢酶(GLDH)的表达水平及其临床意义。方法 选取2005年1月～2015年12月于榆林市第一医院肝胆外科手术切除的160例ECC患者组织标本作为病例组,另选同期胆管正常组织标本30例作为对照组。采用免疫组织化学染色法检测GLDH表达情况,统计分析ECC患者肿瘤组织GLDH表达水平与临床病例特征及预后的相关性。结果 病例组GLDH低表达、中表达和高表达分别占28.1%(45/160),35.6%(57/160)和36.2%(58/160); 对照组为73.3%(22/30),23.3%(7/30)和3.3%(1/30),两组比较差异具有统计学意义(χ2=24.590,P=0.000)。ECC患者肿瘤组织GLDH表达与患者年龄、CD34表达情况、细胞分化程度及有无神经浸润均密切相关(χ2=12.145～158.075,均P<0.05)。GLDH低表达、中表达、高表达ECC患者平均生存时间分别为44.3个月、26.0个月和11.6个月,3组生存曲线差异有统计学意义(χ2=18.367,P=0.001)。Cox多因素分析结果显示肿瘤组织GLDH高表达是ECC患者预后不良的独立危险因素(HR=3.873,95%CI 1.515～9.903,P=0.005)。结论 GLDH可能成为ECC患者预后的评价指标。
Abstract:
Objective To investigate the expression and clinical significance of glutamate dehydrogenase(GLDH)in tumor tissues in patients with extrahepatic cholangiocarcinoma(ECC).Methods A total of 160 cases of ECC resections collected from January 2005 to December 2015were recruited to participate in the study as the case group.Meanwhile,30 samples of normal bile duct tissue were taken as the control.The expression of GLDH in 160 cases of ECC and 30cases of normal bile duct tissue were detected by immunohistochemistry(IHC).Statistical analysis was used to analyze the correlation between GLDH and clinicopathological features and prognosis.Results Low,moderate and high expression rate of GLDH in case group were28.1%(45/160),35.6%(57/160)and 36.2%(58/160),respectively,and in control group,they were 73.3%(22/30),23.3%(7/30)and 3.3%(1/30),respectively.The difference was statistically significant.GLDH expression level was correlated to patient age,CD34 expression,cellular differentiation and neural invasion in ECC tissues(χ2=12.145～158.075,all P<0.05).Mean survivaltime of low,moderate and high GLDH expression in case group were 44.3 months,26.0 months and 11.6 months,respectively.Log-rank test showed highly significant differences in overall survival between different GLDH expression(χ2=18.367,P=0.001).Cox multivariate analysis showed that high GLDH expression was independently associated with ECC poor prognosis(HR=3.873,95%CI:1.515～9.903,P=0.001).Cox multivariate analysis showed that high GLDH expression was independently associated with ECC poor prognosis(HR=3.873,95%CI:1.515～9.903,005).Conclusion GLDH may be an important prognostic indicator of ECC.

参考文献/References:

[1] Esnaola NF,Meyer JE,Karachristos A,et al.Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma[J].Cancer,2016,122(9):1349-1369.
[2] 肖小平,郭 玲,张 熊.胆管癌组织LOXL2mRNA与Tenascinm-C mRNA表达的临床应用研究[J].现代检验医学杂志,2017,32(3):79-81.
Xiao XP,Guo L,Zhang X.Clinical application of the expression of LOXL2 mRNA and tenascin-C mRNA in tissues of the bile duct cancer[J].Journalof Modern Laboratory Medicine,2017,32(3):79-81.
[3] 易婷婷,罗光成,胡 帅,等.血浆谷氨酸脱氢酶活性测定在肝胆疾病中的临床应用评价[J].川北医学院学报,2016,31(4):532-534.
Yi TT,Luo GC,Hu S,et al.The clinical significance of plasma GLDHactivity in patients with liver disease[J].Journal of North Sichuan MedicalCollege,2016,31(4):532-534.
[4] Jin L,Li D,Alesi GN,et al.Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth[J].Cancer Cell,2015,27(2):257-270.
[5] Nissen JD,Pajecka K,Stridh MH,et al.Dysfunctional TCA-Cycle metabolism in glutamate dehydrogenase deficient astrocytes[J].Glia,2015,63(12):2313-2326.
[6] McKenna MC,Stridh MH,McNair LF,et al.Glutamate oxidation in astrocytes:roles of glutamate dehydrogenase and aminotransferases[J].J Neurosci Res,2016,94(12):1561-1571.
[7] Pajecka K,Nissen JD, Stridh MH,et al.Glucose replaces glutamate as energy substrate to fuel glutamate uptake in glutamate dehydrogenase-deficient astrocytes[J].J Neurosc Res,2015,93(7):1093-1100.
[8] Csibi A,Lee G,Yoon SO,et al.The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc,translation[J].Curr Biol,2014,24(19):2274-2280.
[9] Jeong SM,Xiao C,Finley LW,et al.SIRT4 has tu-mor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism[J].Cancer Cell,2013,23(4):450-463.
[10] Son J,Lyssiotis CA,Ying HQ,et al.Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway[J].Nature,2013,496(7443):101-105.
[11] Khan N,Bharali DJ,Adhami VM,et al.Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model[J].Carcinogenesis,2014,35(2):415-423.
[12] Shukla R,Chanda N,Zambre A,et al.Laminin receptor specific therapeutic gold nanoparticles(198AuNP-EGCg)show efficacy in treatingprostate cancer[J].Proc NatI Acad Sci USA,2012,109(31):12426-12431.
[13] Yang LF,Moss T,Mangala LS,et al.Metabolic shi-fts toward glutamine regulate tumor growth,invasion and bioenergetics in ovarian cancer[J].Mol Syst Biol,2014,10(5):728.
[14] Chen R,Nishimura MC,Kharbanda S,et al.Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma[J].Proc NatI Acad Sci USA,2014,111(39):14217-14222.

备注/Memo

备注/Memo:
基金项目:陕西省自然科学基础研究计划项目(2012JQ4016)。
作者简介:侯建峰(1976-),男,本科,副主任医师,研究方向:肝胆外科基础研究和临床治疗,E-mail:yulinhoujfeng@163.com。
通讯作者:王 莉,女,本科,主治医师,榆林市第一医院体检中心,E-mail: 916027091@qq.com。
更新日期/Last Update: 2018-11-30